biontech.de (BNTX) Company Sales Volume
The investment potential of BioNTech SE (BNTX) is limited by fierce competition with capital-intensive oncology behemoths. The company's commercial revenue level clearly demonstrates this trend, where 2.80 serves as the final benchmark. Patents and regular vaccination payments provide stability, while future growth relies on the results of new clinical trials amid the saturation of legacy markets.
Analytical breakdowns for BioNTech SE
- price and consensus price forecast:
- market capitalization details:
- issuer book value statistics:
- debt and solvency information:
- business earnings and investment ratios data:
BNTX - Net Profit|Future Profit BioNTech SE|BNTX - P/E Multiple|Future Price to Earnings Multiple biontech.de|BNTX - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation BioNTech SE|BNTX - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters BioNTech|BNTX - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months biontech.de|BNTX - Earnings growth in current year|Net earnings per share growth forecast for next year BioNTech SE
- company sales and revenue statistics:
Comprehensive company analysis:BioNTech Pharma BNTX
Sales represent the aggregated cash flow from the realization of core products and services. The trend in the company's total sales reflects real-time operational efficiency. This metric allows for an assessment of market demand and the pace of intellectual property monetization. For BioNTech SE (BNTX), this flow is generated through the commercialization of mRNA technologies within global partnerships. Strategic alliances with pharma behemoths directly determine the scale of incoming revenue.
Competing companies
Revenue and Sales Volume argenx BVBA|Company Revenue Abivax (ABVX)|admabiologics.com - Company Sales Volume|Revenue and Sales Volume PTGX (Protagonist)|Immunovant Inc (IMVT) - Company Total Revenue|Kiniksa Pharmaceuticals Ltd - Revenue and Sales Volume|GRFS: Company Revenue|ADPT: Revenue and Sales Volume|CLDX - Company Gross Revenue|Company Revenue Aurinia Pharmaceuticals Inc.|Company Total Revenue BioCryst Pharmaceuticals, Inc. BCRX|Company Revenue Vera Pharma (VERA)|Dianthus Corp - Company Sales Volume|Pharvaris N.V. - Company Sales|Company Total Sales ABCL (abcellera.com)|Tourmaline Bio - Revenue and Sales Volume|Company Total Revenue Precigen Inc|PHAR: Revenue and Sales Volume|Company Sales Nektar Corp|UPB (Upstream Bio Inc) - Revenue and Sales Volume|ZBIO: Company Sales Revenue|Company Sales IMNM (Immunome)|GOSS (Gossamer Bio Inc) - Company Sales Revenue|Company Revenue KalVista Pharmaceuticals Inc KALV|Company Gross Revenue Septerna Pharma (SEPN)|Pieris Pharmaceuticals - Revenue and Sales Volume|Company Total Revenue savarapharma.com|RIGL: Revenue and Sales Volume|ANAB (AnaptysBio Inc) - Company Revenue|Company Revenue Astria Pharma|Company Sales Volume ENGN (enGene Corp)|Company Sales RAPT (RAPT Therapeutics, Inc.)|Company Total Sales JBIO|Aclaris Therapeutics, Inc. - Company Sales|KYTX: Company Sales Volume|TLSA - Company Revenue|Company Annual Revenue CABA|VTYX: Revenue and Sales Volume|theratech.com - Company Sales Revenue|AVTX (Avalo Therapeutics) - Revenue and Sales Volume|Revenue and Sales Volume Eledon Pharmaceuticals Inc.|Company Revenue Agenus Inc (AGEN)|CLYM (Climb Bio, Inc) - Company Sales Revenue|Company Revenue Zura Bio Limited ZURA|ATYR - Company Sales|Adagene Corp - Revenue and Sales Volume|IMA - Revenue and Sales Volume|STTK (shattucklabs.com) - Company Sales|Equillium - Company Sales Revenue|CNTB (Connect Biopharma Holdings) - Revenue and Sales Volume|Immunic Inc (IMUX) - Company Gross Revenue|Company Revenue Atara Biotherapeutics (ATRA)|Company Sales inflarx.de IFRX|Company Revenue X4 Pharma XFOR|ACET - Company Sales|CELU: Company Sales|INMB - Revenue and Sales Volume|Barinthus Biotherapeutics plc (BRNS) - Company Revenue|Company Sales Volume KZR|SABS (SAB Biotherapeutics, Inc) - Revenue and Sales Volume|Company Total Revenue Akari Therapeutics, Plc AKTX|Revenue and Sales Volume ENLV|Company Revenue QTTB (q32bio.com)|Revenue and Sales Volume GOVX (GeoVax)|Company Gross Revenue Edesa Biotech Inc (EDSA)|IBIO - Company Revenue|Company Total Revenue Carisma Therapeutics|XTL Biopharmaceuticals (XTLB) - Company Revenue|Company Sales Volume BOLT|Company Sales HCWB|APVO (Aptevo) - Company Total Sales|Revenue and Sales Volume AIM|ADTX - Company Total Revenue|Revenue and Sales Volume GRI (GRI Bio, Inc.)|XRTX - Company Sales|Vyome Holdings - Revenue and Sales Volume|Company Sales Revenue REVB (Revelation Biosciences Inc)|INDP (Indaptus) - Company Sales|BiondVax Pharmaceuticals - Company Sales Revenue|Company Revenue CalciMedica Inc|Affimed Therapeutics (AFMD) - Company Gross Revenue|Revenue and Sales Volume ALLK|HOOK - Company Total Revenue|Revenue and Sales Volume IGMS (IGM Biosciences)|iTeos Pharma - Company Revenue|OCEA - Company Revenue|TCBP (tcbiopharm.com) - Company Sales Volume|THRD (Third Harmonic Bio, Inc.) - Company Sales
